Patency of the ductus arteriosus (PDA) and bronchopulmonary dysplasia (BPD) development represent severe affections for premature newborns, therefore the research of early markers for these two conditions is really important. The aim of this study is to analyze epithelial lining fluid (ELF) Neutrophil-gelatinase-associated lipocalin (NGAL) levels for prediction of lung injury or possible involvement ofthis molecule in PDA. Only scarce and contrasting results have previously been published in this field. In contrast, this molecule, included in a large macromolecular complex together with matrix metalloproteinase-9 (MMP-9), is considered an acceptable marker of infectious/inflammatory processes, cancer monitoring and induction of apoptotic pathway. NGAL was detected in 28 pre-term newborns by means of a commercially available kit in bronchoalveolar lavage fluid (BALF). The results have been corrected to ELF levels, by the urea method, to eliminate bias due to BALF collection. ELF NGAL levels were found significantly increased both in infants developing BPD or in those affected by PDA. By means of multivariate logistic regression analysis the significances were confirmed after adjusting for possible interfering variables such as gestational age and concomitant presence of both PDA and BPD. Our results stress the involvement of NGAL in the mechanisms leading to BPD and also suggest a possible association with PDA, which is often linked to prematurity and BPD development, probably due to the involvement of inflammatory and angiogenetic processes in both pathologies.
various inflammatory mechanisms, including acute phase proteins and the vascular repair process (5) (6) (7) (8) .
It is plausible that NGAL produced by vascular cells could be secreted into the circulation, thus affecting its serum level, and suggesting exploration of its suitability as a marker of vascular injury (5) and potentially of ductus arteriosus patency (PDA) (9) . In fact, indometacin, a drug used in cases ofnewborn PDA, has been reported to decrease MMP-9 synthesis and release (10) (11) and also to reduce IL-l-beta (6) (7) (8) up-regulation of NGAL, although in a different field and in a rat model (7, 12) . Dexamethasone or retinoic acid treatment are able to increase NGAL synthesis as well as oxygenation (13) , vascular injury and oxidative stress (14) . Increased NGAL levels have recently been .found at the 2 nd and 4 th day of life in BALF of premature infants not developing bronchopulmonary disease (BPD) (8) , while subsequent increases were observed on the T" and l O" day in BPD infants. Further observations have been reported by Sveger T et al. (16) on sera, showing no association with BPD. Previous data suggested that the highest MMP-9 levels could be considered an important event in BPD induction (5, (17) (18) , while Ekekezie et al. (19) underlined that TIMP-l, an inhibitor ofMMP-9, was low when BPD was present and MMP-9 level was high, suggesting that inhibitors were not sufficient to block the MMP-9 function. Differently.from TIMP ligands, NGAL is an enhancer of MMP-9 function (4).
. Since BPD development and PDA may represent severe affections for premature infants, the research of early markers for these two conditions are still very important. Therefore, the aim of this study is to analyze ELF NGAL levels for a possible early association with subsequent BPD development, in the presence or not of PDA.
MATERIALS AND METHODS
This study was carried out in the Neonatal Intensive Care Unit (NICU) of the Catholic University of Rome and included 28 premature babies consecutively admitted between September 2006 and February 2007. Neonates with gestational age (GA) <32 weeks and respiratory distress syndrome were studied. They were eligible inborn, when endotracheal intubation was required at birth, and on-going intensive care was required. Newborns with major congenital malformations, prenatal infection, severe asphyxia (Apgar score < 5 at l' and 5'), or babies treated with early (first 96 hours of life) dexamethasone therapy or infants enrolled into the study but died before BPD diagnosis was made, were all excluded from final analysis. The study protocol and consent forms were approved by the Ethics Committee of the Department of Paediatrics. Pre-term newborns were studied by echocardiography on the yd day of life, after a prophylactic ibuprofen course, in order to evaluate the patency of ductus arteriosus (PDA). A ductus was considered hemodynamically significant when its internal diameter was >1.5 mm with typical Doppler patterns. At the same time bronchoalveolar lavage fluid (BALF) specimens were collected, according to a standardized procedure (20) . VEGF concentrations were determined by ELISA and expressed as epithelial lining fluid (ELF) values, after correction by the Urea method (21) .
Surfactant (a pig-derived, natural surfactant, Curosurf, Chiesi Farmaceutici, Parma, Italy) was administered at a dose of 200 mg/kg as soon as possible after birth, always in the neonatal unit. All the babies were ventilated in high frequency oscillatory ventilation (HFOV) modality with Draeger Babylog 8000 plus (Draeger, Lubeck, Germany), as previously described (20) , and received prophylactic ibuprofen: 10 mg/kg i.v. on the first day of life, followed by two doses of 5 mg/kg i.v. on the 2 nd and 3 rd day of life (22) . Neonates who subsequently developed PDA received a 2 nd ibuprofen course and, in case of failure, underwent surgical ligation. Babies were extubated on. continuous nasal positive airway pressure (CPAP) of 4-5 cmHp.
BPD was defined as supplemental oxygen dependency beyond 36 weeks post-conceptional age (23) .
BALF collections
BALF samples were centrifuged at 800 x g for five minutes at 4°C and were then subdivided into two aliquots both stored at -80°C until analyzed. To normalize the dilution bias resulting from the BALF collection practice, a measurement of the urea BALF and serum concentrations was performed in duplicate by means of a colorimetric assay (Urea Nitrogen suitable on Olympus AU2700). The ratio serurn/BALF urea was used as a multiplying coefficient to transform BALF into epithelial lung fluid (ELF) concentrations for the different molecules. BALF samples were cultured for microbiological analysis of bacteria, Ureaplasma urealyticum, Chlamydia and fungi, in order to diagnose lung infection or colonization. Culture-positive BALF specimens, or those with visible blood staining, were excluded from final analysis.
NGAL determination
NGAL was assayed by means of a commercially available kit (NGAL Rapid ELISA kit -IVD, Antibody Shop A7S Denmark) testing all samples in duplicate. The mean value of two duplicates was used as the final result for each individual. The coefficient of variation between all duplicates was less than 15%. The detection limit of the test was <0.1 ng/ml and no samples were found under this value.
Statistical analysis
This report primarily employed univariate analysis of the data by means of non-parametric tests (Mann and Whitman for quantitative and Yates' corrected X 2 or Fisher's exact test for categorical data).
To eliminate the possibility that some variables could interfere with the significances found, a multivariate logistic regression analysis was applied thereafter by using the SPSS version 6.0 for Microsoft Windows 95/ 98. This model applies the stepwise logistic regression ("SPSS backward LR method").
RESULTS

Characteristics ofthe patients analyzed
During the study period 32 patients met the entry criteria. Two neonates with late-diagnosed congenital pneumonia (positive BALF culture at birth), as well as one baby treated with early (first 96 hours of life) dexamethasone therapy and one infant who died before BPD diagnosis was made, were subsequently excluded. Analyses were performed on the remaining 28 neonates. Table I reports some basal characteristics of the studied infants. The major part of the newborns underwent a caesarean delivery, as expected for this type of patient, most of them being very preterm infants. As far as the BPD development was concerned, no significant differences were found for the principal basal variables. A significantly higher number of subjects with premature rupture of membranes was found in the BPD-positive group (p= 0.03). As expected, some of the outcome linked variables were associated with the BPD development, in particular the hours of mechanical ventilation, 02 treatment and CPAP, days of hospitalization and the number of hemotransfusions, all variables linked to the worst clinical situation of infants developing BPD.
As far as the PDA is concerned, no significant differences were noted for the basal variables, while only extubation day was found to be associated, indicating that the infants affected by PDA, although often coinciding with those affected with BPD, were not necessarily the same. The babies suffering from PDA received a significantly higher Fi0 2 on day 3 in respect to the control group: 0.37 ± 0.10 vs 0.27 ± O.l2(p<0.05), respectively, despite similar values of mean airway pressure: 7.8 ± 2.0 cmlI.O vs 7.2 ± 1.6 cmHp, respectively (P>0.05). Table II analyzes the possible association between BPD and PDA. The data presented are clearly in agreement with the previous indication that both BPD and PDA are associated with a significant increase of ELF NGAL values.
ELF NGAL levels observed in function of BPD development or PDA persistence
The univariate distributions of the levels concerning ELF NGAL were significantly increased when the newborns developed BPD or showed a persistence of the PDA (Table II) . To eliminate possible interferences of other variables for the previous BPD comparisons, by applying a multivariate logistic regression analysis, we adjusted the significances for PDA and PROM. The resulting significance, although reduced, was still confirmed.
A similar adjustment was also obtained for the ELF NGAL significant difference regarding the PDA persistence. In this case the variables adjusted were the gestational age and the BPD development. Also, in the last case a significance was confirmed. These results were in keeping with the idea that BPD and PDA were not mutually interfering and that the significances .were independent of gestational age for PDA and premature rupture of membranes for BPD.
DISCUSSION
The results reported in the present study indicate that early (3 rd postnatal day) ELF NGAL levels are associated with BPD development and also with PDA persistence. The possible concomitant presence of these two conditions did not interfere with this significant association as suggested by the multiple regression analysis. No significant differences were observed between subjects individually developing BPD or PDA. Also PROM for BPD and gestational age for PDA were not interfering on the significances observed. Although MMPs have been repeatedly studied in lung injury of premature newborns and also in vascular development of adult humans, data concerning NGAL levels detected in premature newborns are very scarce; the first one (16) showed no differences in ELF NGAL values between infants developing or not BPD, while the second one (8) found that BPD-positive newborns showed significantly higher serum values as compared with BPD-negative babies, but only on the T" and l O"day of life. The results of the last report were obtained by a zymogram methodology and no correction for possible bias due to variability ofBALF dilution was made. It is therefore possible that the differences observed may be due to non-comparability of the two studies.
The observed ELF NGAL increase is also in keeping with previous data reporting that both NGAL and MMP-9, the matrix metalloprotease associated with NGAL to form a functional complex macromolecule, have previously been reported to increase in infectious/inflammatory and cancer diseases (5) (6) (7) (8) . MMPs have been reported to have both inflammatory and anti-inflammatory activities, possibly through TGF-betal activation and VEGF to truncated VEGF cleavage (21) . VEGF, as previously reported, is involved in PDA persistence (24) (25) .
Furthermore, MMP-9 has been shown to be able to recruit inflammatory cells as well as to facilitate the clearance of the same cells (4) . Mouse models of stroke and heart attack were associated with increased MMP-9 molecule synthesis (4). It has been also reported that different inflammatory cytokines may be catabolized by MMPs (4) . The previous observations, taken altogether, may suggest that an MMP-9 increase may be explained both as a cause of inflammation and as a mechanism of blocking inflammatory molecules (4) . NGAL molecules are produced by different cells, including activated neutrophils and macrophages, both cells involved in inflammatory processes. This is in keeping with our observation of increased NGAL values in ELFs of infants developing BPD, a disease often induced by maternal as well as early infant infections, characterized by higher numbers of neutrophils and/or macrophages present in BALF (20, 26) . Although a significant correlation (P=0.04) could be observed (and expected) between the BAL neutrophil number and ELF NGAL levels, these data have not been shown because only 17 infants were analyzed for cellularity (including all those with BPD) out of 28 subjects enrolled. It is possible, therefore, to speculate that, as stated for MMP-9, also the association of NGAL with BPD and PDA may be interpreted as a marker of inflammation. At the present time, the limitations ofthis study, such as the small number of the subjects included, the selection of the patients, the single NGAL determination at the third day of life and the wide dispersion of the ELF NGAL levels with some overlapping ranges, do not permit to establish a clear cut-off to predict for each single infant the exact outcome in terms of BPD or PDA development. For this purpose, more studies on a wider number of subjects are needed, especially to investigate NGAL behaviour over time.
